Co-op at SeLux
Written by Noah Miller, a fourth year bioengineering student.
Noah Miller is a 4th year bioengineering major with a concentration in biomedical devices and a minor in computer science. He is currently on co-op at SeLux Diagnostics for the second time.
Co-op at SeLux
SeLux is a Diagnostic Device Start-up with a focus in Antibiotic Susceptibility Testing (AST) and Next Generation Phenotyping. SeLux’s system aims to reduce the time-to-results for AST and combat the over-prescription of broad-spectrum antibiotics.
My role during my first co-op at SeLux (second co-op overall) as a hardware engineer consisted mainly of characterizing the performance of early prototypes. Now, returning for my second co-op, SeLux is preparing a new generation of devices for FDA trial and my focus has shifted towards writing test case documentation to present in our 510k submission. Due to the interdisciplinary nature of a small company, I have been able to see first hand how each branch of science (specifically biology, chemistry, and engineering) are integrating to design some really cool technology.
During my time here, SeLux has secured their Series B round of funding and was also awarded a grant from the Biomedical Advanced Research and Development Authority (BARDA) and both were huge milestones for the company.
One of the main reasons I have enjoyed my time here is because employees at SeLux make clear how much they value input from co-ops. Showing up for work each day is a lot more engaging when you know your ideas and contributions matter.